OMAHA, Neb. — Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that it has filed an application for listing its common shares on The NASDAQ Capital Market. The Company’s proposed listing on The NASDAQ […]
Washington, D.C.- Danaher Corporation (NYSE:DHR) announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company’s fourth quarter 2013 performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate that the Company’s fourth quarter 2013 adjusted diluted net earnings per […]
SEATTLE — NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed follow-on public offering of $55 million of its common stock. In addition, the Company expects to grant the […]
SAN DIEGO — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today announced preliminary highlights of the Company’s 2013 performance, accomplishments and outlined key corporate objectives for 2014. Preliminary 2013 Performance Results (unaudited) • Total revenue of approximately $162 million, showing growth of approximately 81% year-over-year for 2013 […]
End of December 2013 Biognosys has secured USD 1 million financing in form of a convertible loan. This financing will ensure future growth of the company by expanding its commercial operations and product development. In addition, Biognosys strengthened the existing management team by appointing Russell Golson as Director of Sales and Dr. Lukas Reiter as […]
PARIS– Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market, just released its consolidated sales figures for the year ended December 31, 2013. Sacha Loiseau, CEO of Mauna Kea Technologies, made the following comment: “Fourth quarter sales are in line with those of the previous year. The sales trend in the […]
LAUSANNE, Switzerland — Spinomix SA, a Swiss company advancing molecular diagnostic through innovative sample preparation technologies and Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the successful achievement of a second development milestone on Spinomix’ two proprietary technologies, namely […]
SAN MATEO, Calif. — Maverix Biomics, Inc., a leading provider of software for next-generation sequencing genomic data analysis, today announced that it has closed a $6 million Series A funding round. The company’s pioneering flagship offering, the Maverix Analytic Platform, simplifies complex big data analytics for life science researchers; integrating context-based data exploration, interactive visualization, […]
NEW YORK – Enzo Biochem Inc. (NYSE:ENZ) reported today that a Federal Court Judge in New Haven, CT, in connection with the favorable November 2012 jury finding of direct infringement damages of Enzo patents by Applera Corp., now Life Technologies Inc. (NASDAQ:LIFE), has awarded the Company prejudgment interest of $12,428,729, bringing the total award to […]
MOUNTAIN VIEW, Calif. — DNAnexus, a pioneer in cloud-based solutions for large-scale DNA data management and analysis, today announced that it has closed a $15 million Series C funding led by Claremont Creek Ventures, Google Ventures, TPG Biotech, and First Round Capital. The company’s innovative Platform-as-a-Service (PaaS), is experiencing rapid customer adoption and delivers a […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
